Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 221

    1.

    HIV-1 replication in cell lines harboring INI1/hSNF5 mutations.

    Sorin M, Yung E, Wu X, Kalpana GV.

    Retrovirology. 2006 Aug 31;3:56.

    PMID:
    16945155
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    2.

    Recruitment of a SAP18-HDAC1 complex into HIV-1 virions and its requirement for viral replication.

    Sorin M, Cano J, Das S, Mathew S, Wu X, Davies KP, Shi X, Cheng SW, Ott D, Kalpana GV.

    PLoS Pathog. 2009 Jun;5(6):e1000463. Epub 2009 Jun 5.

    PMID:
    19503603
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    3.

    Specificity of interaction of INI1/hSNF5 with retroviral integrases and its functional significance.

    Yung E, Sorin M, Wang EJ, Perumal S, Ott D, Kalpana GV.

    J Virol. 2004 Mar;78(5):2222-31.

    PMID:
    14963118
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    4.

    Inhibition of HIV-1 virion production by a transdominant mutant of integrase interactor 1.

    Yung E, Sorin M, Pal A, Craig E, Morozov A, Delattre O, Kappes J, Ott D, Kalpana GV.

    Nat Med. 2001 Aug;7(8):920-6.

    PMID:
    11479624
    [PubMed - indexed for MEDLINE]
    5.

    Multimerization and DNA binding properties of INI1/hSNF5 and its functional significance.

    Das S, Cano J, Kalpana GV.

    J Biol Chem. 2009 Jul 24;284(30):19903-14. Epub 2009 Apr 27.

    PMID:
    19398554
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    6.

    Integrase interactor 1 (Ini1/hSNF5) is a repressor of basal human immunodeficiency virus type 1 promoter activity.

    Boese A, Sommer P, Holzer D, Maier R, Nehrbass U.

    J Gen Virol. 2009 Oct;90(Pt 10):2503-12. Epub 2009 Jun 10.

    PMID:
    19515827
    [PubMed - indexed for MEDLINE]
    Free Article
    7.

    Cell cycle arrest and repression of cyclin D1 transcription by INI1/hSNF5.

    Zhang ZK, Davies KP, Allen J, Zhu L, Pestell RG, Zagzag D, Kalpana GV.

    Mol Cell Biol. 2002 Aug;22(16):5975-88.

    PMID:
    12138206
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    8.

    Inhibition of early stages of HIV-1 assembly by INI1/hSNF5 transdominant negative mutant S6.

    Cano J, Kalpana GV.

    J Virol. 2011 Mar;85(5):2254-65. Epub 2010 Dec 15.

    PMID:
    21159874
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    9.

    Aberrations of the hSNF5/INI1 gene are restricted to malignant rhabdoid tumors or atypical teratoid/rhabdoid tumors in pediatric solid tumors.

    Uno K, Takita J, Yokomori K, Tanaka Y, Ohta S, Shimada H, Gilles FH, Sugita K, Abe S, Sako M, Hashizume K, Hayashi Y.

    Genes Chromosomes Cancer. 2002 May;34(1):33-41.

    PMID:
    11921280
    [PubMed - indexed for MEDLINE]
    10.

    RhoA-dependent regulation of cell migration by the tumor suppressor hSNF5/INI1.

    Caramel J, Quignon F, Delattre O.

    Cancer Res. 2008 Aug 1;68(15):6154-61.

    PMID:
    18676838
    [PubMed - indexed for MEDLINE]
    Free Article
    11.

    The integrase interactor 1 (INI1) proteins facilitate Tat-mediated human immunodeficiency virus type 1 transcription.

    Ariumi Y, Serhan F, Turelli P, Telenti A, Trono D.

    Retrovirology. 2006 Aug 5;3:47.

    PMID:
    16889668
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    12.

    Virion-targeted viral inactivation: new therapy against viral infection.

    Okui N, Kitamura Y, Kobayashi N, Sakuma R, Ishikawa T, Kitamura T.

    Mol Urol. 2001 Summer;5(2):59-66.

    PMID:
    11690549
    [PubMed - indexed for MEDLINE]
    13.

    Aurora A is a repressed effector target of the chromatin remodeling protein INI1/hSNF5 required for rhabdoid tumor cell survival.

    Lee S, Cimica V, Ramachandra N, Zagzag D, Kalpana GV.

    Cancer Res. 2011 May 1;71(9):3225-35. Epub 2011 Apr 26.

    PMID:
    21521802
    [PubMed - indexed for MEDLINE]
    14.

    hSNF5/INI1 inactivation is mainly associated with homozygous deletions and mitotic recombinations in rhabdoid tumors.

    Rousseau-Merck MF, Versteege I, Legrand I, Couturier J, Mairal A, Delattre O, Aurias A.

    Cancer Res. 1999 Jul 1;59(13):3152-6.

    PMID:
    10397258
    [PubMed - indexed for MEDLINE]
    Free Article
    16.

    The tumor suppressor hSNF5/INI1 modulates cell growth and actin cytoskeleton organization.

    Medjkane S, Novikov E, Versteege I, Delattre O.

    Cancer Res. 2004 May 15;64(10):3406-13.

    PMID:
    15150092
    [PubMed - indexed for MEDLINE]
    Free Article
    17.

    A key role of the hSNF5/INI1 tumour suppressor in the control of the G1-S transition of the cell cycle.

    Versteege I, Medjkane S, Rouillard D, Delattre O.

    Oncogene. 2002 Sep 19;21(42):6403-12.

    PMID:
    12226744
    [PubMed - indexed for MEDLINE]
    Free Article
    18.

    Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors.

    Biegel JA, Tan L, Zhang F, Wainwright L, Russo P, Rorke LB.

    Clin Cancer Res. 2002 Nov;8(11):3461-7.

    PMID:
    12429635
    [PubMed - indexed for MEDLINE]
    Free Article
    19.

    The tumour suppressor hSNF5/INI1 controls the differentiation potential of malignant rhabdoid cells.

    Albanese P, Belin MF, Delattre O.

    Eur J Cancer. 2006 Sep;42(14):2326-34.

    PMID:
    16908131
    [PubMed - indexed for MEDLINE]
    20.

    Inhibition of early steps of HIV-1 replication by SNF5/Ini1.

    Maroun M, Delelis O, Coadou G, Bader T, Ségéral E, Mbemba G, Petit C, Sonigo P, Rain JC, Mouscadet JF, Benarous R, Emiliani S.

    J Biol Chem. 2006 Aug 11;281(32):22736-43. Epub 2006 Jun 13.

    PMID:
    16772295
    [PubMed - indexed for MEDLINE]
    Free Article

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk